VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $0 | -100.0% | 57 | -83.6% | 0.00% | -100.0% |
| Q3 2016 | $8,000 | +14.3% | 347 | 0.0% | 0.00% | -25.0% |
| Q2 2016 | $7,000 | -97.6% | 347 | +4237.5% | 0.00% | – |
| Q1 2016 | $290,000 | +491.8% | 8 | -98.3% | 0.00% | -100.0% |
| Q4 2015 | $49,000 | -19.7% | 480 | +40.8% | 0.02% | -52.2% |
| Q3 2015 | $61,000 | +84.8% | 341 | +130.4% | 0.05% | +91.7% |
| Q2 2015 | $33,000 | -99.9% | 148 | 0.0% | 0.02% | +20.0% |
| Q1 2015 | $29,396,000 | – | 148 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |